[1]朱磊,方祥,周正新,等.腰突方联合单侧双通道内镜技术治疗腰椎间盘突出症的临床疗效观察[J].中国中医骨伤科杂志,2025,33(05):32-36.[doi:10.20085/j.cnki.issn1005-0205.250507]
　ZHU Lei,FANG Xiang,ZHOU Zhengxin,et al.Clinical Efficacy Observation of Lumbar Disc Herniation Treated with Yaotu Formula Combined with Unilateral Dual Channel Endoscopic Technique[J].Chinese Journal of Traditional Medical Traumatology & Orthopedics,2025,33(05):32-36.[doi:10.20085/j.cnki.issn1005-0205.250507]
点击复制

腰突方联合单侧双通道内镜技术治疗腰椎间盘突出症的临床疗效观察()
分享到：

《中国中医骨伤科杂志》[ISSN:1005-0205/CN:42-1340/R]

卷:
第33卷
期数:
2025年05期
页码:
32-36
栏目:
临床研究
出版日期:
2025-05-05

文章信息/Info

Title:
Clinical Efficacy Observation of Lumbar Disc Herniation Treated with Yaotu Formula Combined with Unilateral Dual Channel Endoscopic Technique
文章编号:
1005-0205(2025)05-0032-05
作者:
朱磊1; 2; 方祥1; 2; 周正新1; 陈家康3; 徐寰1
1安徽中医药大学第一附属医院(合肥,230031); 2安徽中医药大学第一临床医学院; 3安徽中医药大学
Author(s):
ZHU Lei1; 2; FANG Xiang1; 2; ZHOU Zhengxin1; CHEN Jiakang3; XU Huan1
1The First Affiliated Hospital of Anhui University of Chinese Medicine,Hefei 230031,China; 2The First Clinical Medical College of Anhui University of Chinese Medicine,Hefei 230031,China; 3Anhui University of Chinese Medicine,Hefei 230031,China.
关键词:
腰椎间盘突出症;  腰突方;  单侧双通道内镜技术;  临床疗效
Keywords:
lumbar disc herniation;  Yaotu formula;  unilateral biportal endoscopic technique;  clinical efficacy
分类号:
R681.5
DOI:
10.20085/j.cnki.issn1005-0205.250507
文献标志码:
A
摘要:
目的:探讨腰突方联合单侧双通道内镜(UBE)技术治疗腰椎间盘突出症(LDH)的临床疗效。方法:选取2022年1月至2024年10月收治的60例腰椎间盘突出症患者,利用随机数表法将其分为对照组(30例)和观察组(30例)。两组患者均采用单侧双通道内镜技术完成手术治疗,观察组患者在此基础上连续口服腰突方4周。通过比较两组患者治疗前、治疗后第1周、第4周及第6周的疼痛视觉模拟量表(VAS)评分、Oswestry功能障碍指数(ODI)评分、日本骨科协会(JOA)评分,评价其临床疗效,并于治疗后第6周采用改良MacNab评分进行临床疗效评定。结果:治疗后第1周VAS评分和ODI评分均低于治疗前,差异有统计学意义(P<0.05),JOA评分与治疗前比较差异无统计学意义(P>0.05),观察组患者与对照组各项指标差异无统计学意义(P>0.05); 治疗后第4周和第6周两组患者的VAS评分及ODI评分均低于治疗前,差异有统计学意义(P<0.05),JOA评分均高于治疗前,差异有统计学意义(P<0.05),且观察组患者的VAS评分和ODI评分较对照组明显降低,差异有统计学意义(P<0.05),JOA评分明显升高,差异有统计学意义(P<0.05)。治疗后第6周观察组患者改良MacNab评分总有效率为93.33%,优于对照组患者的66.67%,差异有统计学意义(P<0.05)。结论:腰突方联合单侧双通道内镜技术治疗腰椎间盘突出症效果优于单纯应用单侧双通道内镜技术治疗,可进一步缓解患者临床疼痛症状,提升腰椎功能,临床疗效更好。
Abstract:
Objective:To investigate the clinical efficacy of Yaotu formula combined with unilateral dual-channel endoscopy(UBE)in the treatment of lumbar disc herniation(LDH).Methods:A total of 60 patients with LDH from January 2022 to October 2024 were selected and divided into control group(30 cases)and observation group(30 cases)by random number table method.Both groups were treated with UBE technology,and the observation group was treated with Yaotu formula for 4 weeks on this basis.The visual analogue scale(VAS)score,Oswestry disability index(ODI)score and Japanese orthopaedic association(JOA)score were compared between the two groups before treatment and at 1,4 and 6 weeks after treatment.The modified MacNab scale was used to evaluate the clinical efficacy at 6 weeks after treatment.Results:After treatment,the VAS and ODI scores at 1 week after treatment were lower than those before treatment(P<0.05),and there was no significant difference in JOA score between before and after treatment(P>0.05).There was no significant difference in each index between the observation group and the control group(P>0.05).At 4 and 6 weeks after treatment,the VAS and ODI scores of the two groups were lower than those before treatment(P<0.05),and the JOA scores were higher than those before treatment(P<0.05),and the VAS and ODI scores of the observation group were significantly lower than those of the control group(P<0.05),and the JOA score was significantly increased(P<0.05).At 6 weeks after treatment,the total effective rate of modified MacNab score in the observation group was 93.33%,which was better than 66.67% in the control group(P<0.05).Conclusion:The effect of Yaotu formula combined with UBE technology in the treatment of LDH is better than that of single use of UBE technology,which can further relieve the clinical pain symptoms of patients,improve the function of lumbar spine,and have better clinical efficacy.

参考文献/References:

[1] 秦晓宽,孙凯,冯天笑,等.腰椎间盘突出症临床实践指南和专家共识的方法学质量评价与综合分析[J].中国全科医学,2024,27(31):3857-3864.
[2] 黄吉军,王永祥,杨建东,等.单侧双通道脊柱内镜技术治疗脱垂型腰椎间盘突出症的早期疗效[J].中国修复重建外科杂志,2024,38(11):1367-1371.
[3] 张玉红,冯波,苏炜良,等.单侧双通道脊柱内镜技术椎管减压术治疗双节段腰椎管狭窄症的早期临床疗效[J].中国修复重建外科杂志,2023,37(6):706-712.
[4] 左如俊,马明,蒋毅,等.经椎板间入路单侧双通道脊柱内镜技术与经椎板间窗单通道内镜技术治疗L5、S1椎间盘突出症疗效比较[J].中国修复重建外科杂志,2022,36(10):1192-1199.
[5] 宋凤宝.“腰突方”外敷结合中药治疗腰椎间盘突出症90例[J].山西中医学院学报,2013,14(3):48-49.
[6] CHENG Z X,ZHENG Y J,FENG Z Y,et al.Chinese association for the study of pain:expert consensus on diagnosis and treatment for lumbar disc herniation[J].World J Clin Cases,2021,9(9):2058-2067.
[7] 世界中医药学会联合会骨质疏松专业委员会,上海中医药大学附属龙华医院,中日友好医院,等.腰椎间盘突出症中西医结合诊疗专家共识[J].世界中医药,2023,18(7):945-952.
[8] JIANG H W,CHEN C D,ZHAN B S,et al.Unilateral biportal endoscopic discectomy versus percutaneous endoscopic lumbar discectomy in the treatment of lumbar disc herniation:a retrospective study[J].J Orthop Surg Res,2022,17(1):30.
[9] 潘其鹏,孔凡国,付拴虎,等.单侧双通道内镜治疗复发性腰椎间盘突出症[J].中国矫形外科杂志,2024,32(19):1816-1820.
[10] 王国军,张世民,靳蛟,等.七芍活血方治疗气滞血瘀型腰椎间盘突出症疗效及血液流变学和血清炎性因子的影响[J].中国实验方剂学杂志,2024,30(24):159-166.
[11] 王新立,刘汝银,王西彬,等.黄芪甲苷经由miR-125a-5p/NLRP1轴减轻椎间盘突出髓核细胞损伤[J].沈阳药科大学学报,2024,41(7):929-938.
[12] 周杰,徐露.红花黄色素对神经根型腰椎病大鼠抗炎作用及其机制研究[J].中药药理与临床,2016,32(4):41-44.
[13] 白雪,孙孝先,郭杨,等.益气活血方对大鼠腰椎间盘突出的影响及机制[J].中国药房,2024,35(10):1186-1192.
[14] 熊雨墨,李梓宸,李瑛,等.通督活血汤对腰椎间盘突出症急性期患者腰椎功能及血清炎症因子水平的影响[J].中国实验方剂学杂志,2024,30(13):135-141.

备注/Memo

备注/Memo:
基金项目:国家中医药管理局全国名中医传承工作室建设项目(czbkjf20200037)
丁锷全国名中医传承工作室项目安徽省自然科学基金面上项目(2008085MH281)
安徽省教育厅高校自然科学研究重大项目(2023AH040109)
更新日期/Last Update: 2025-05-15